Agios Pharmaceuticals Shares up 5% After Rival Pfizer Withdraws Sickle Cell Disease Treatment
agios pharmaceuticals股價上漲5%,競爭對手輝瑞退出鐮狀細胞病治療
Agios Pharmaceuticals Shares up 5% After Rival Pfizer Withdraws Sickle Cell Disease Treatment
agios pharmaceuticals股價上漲5%,競爭對手輝瑞退出鐮狀細胞病治療
譯文內容由第三人軟體翻譯。